Keywords: fujisawa, nexstar, file, ambisome, healthcare, pharmaceuticals, filed

Fujisawa and NeXstar file for AmBisome

Article | 15 July 1999

Fujisawa Healthcare and NeXstar Pharmaceuticals have filed forapproval to market the antifungal AmBisome (amphotericin B liposome for injection) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Amphotericin B

Ambisome

Fungizone

Abelcet

Amino Acids

Go to drug listing